BBK Capital Partners »

Sonnet Biotherapeutc Hldng I shares owned by BBK Capital Partners

Quarter-by-quarter ownership of Sonnet Biotherapeutc Hldng I (SONN) shares owned by BBK Capital Partners from 13F filings

Historical chart of BBK Capital Partners investment in Sonnet Biotherapeutc Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Sonnet Biotherapeutc Hldng I held by BBK Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sonnet Biotherapeutc Hldng I by BBK Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $170k 37k 4.58

More positions owned by BBK Capital Partners

Apple (AAPL)
Procter & Gamble Company (PG)
Microsoft Corporation (MSFT)
Etf Opportunities Trust Formidable Fortr (KONG)
Etf Opportunities Trust Formidable Etf (FORH)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Flux Pwr Hldgs Com New (FLUX)
Eli Lilly & Co. (LLY)
Alibaba Group Hldg Sponsored Ads (BABA)
Amazon (AMZN)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Eaton Vance Tax-Managed Global Dive Eq (EXG)
Ishares Tr Msci Usa Qlt Fct (QUAL)

View all positions for BBK Capital Partners

Top funds holding Sonnet Biotherapeutc Hldng I

Ikarian Capital
Hrt Financial
Geode Capital Management
Boothbay Fund Management
Goldman Sachs Group
Citadel Advisors
BBK Capital Partners
Virtu Financial
State Street Corporation
BlackRock
Northern Trust
Two Sigma Investments
Investment House
Jane Street
Jpmorgan Chase & Co

View all funds holding Sonnet Biotherapeutc Hldng I